|
Listen to this text  |
Siemens Healthineers introduced its Corindus firm rebranded to “Siemens Healthineers Endovascular Robotics.”
In 2019, Siemens Healthineers acquired Corindus for $1.1 billion. Corindus develops the CorPath robot-assisted gadget for coronary and peripheral vascular procedures.
According to Siemens, model unification represents “the final step” within the firm integration course of that started in 2019. The enterprise goals to advance interventions with robotics, altering the supply of care via improvements. These improvements improve doctor strategies and produce precision to interventional procedures, Siemens mentioned.
Siemens mentioned it now provides the Endovascular Robotics enterprise entry to its company-wide assets. That permits it to proceed advancing its imaginative and prescient of growing image-guided robotic options. It intends to proceed providing the CorPath GRX system to assist endovascular procedures.
All Corindus channels, together with its web site and social media profiles, will formally shut down on Dec. 16, 2022. Siemens plans to make all supplies beforehand shared on the Corindus web site accessible by itself. The general rebranding transition stays underway.
“The completion of our brand evolution marks the final step to becoming a united company and we remain focused on pioneering breakthroughs for everyone, everywhere,” mentioned Wayne Markowitz, worldwide EVP of Siemens Healthineers and head of Endovascular Robotics. “Our flagship product, the CorPath GRX System, is designed to support endovascular interventions, and we look forward to working with our customers as Siemens Healthineers Endovascular Robotics while fueling our vision to connect more patients to advanced care.”
Editor’s Note: This article first seem on sister publication MassDevice and was reprinted with permission.